eXciteOSA Daytime Tongue Neurostimulation: Does the 20-Minute Awake Therapy Actually Reduce Snoring?
eXciteOSA Daytime Tongue Neurostimulation: An Honest EU Verdict on the 20-Minute Awake Snoring Therapy
A CE-marked tongue stimulator promises quieter nights after six weeks of daytime use, but the evidence and the EU access reality both deserve a clear, honest read.
What Is eXciteOSA Daytime Tongue Neurostimulation?
eXciteOSA daytime tongue neurostimulation is a CE-marked mouthpiece that sends gentle electrical pulses to your tongue muscles for 20 minutes while you are awake. The goal is to strengthen the genioglossus, the large muscle that keeps the airway open, so the tongue collapses less during sleep. Unlike a surgical implant such as the Genio implant compared with Inspire, eXciteOSA needs no surgery and no nighttime wear.
The device is made by Signifier Medical Technologies and targets primary snoring and mild obstructive sleep apnea (OSA). OSA is a condition where the airway repeatedly narrows or closes during sleep, lowering oxygen levels. Because it works through daytime muscle training rather than mechanics, results take weeks, so many EU snorers also explore faster options on our evidence-based ranking of CPAP alternatives.
You use eXciteOSA once daily for six weeks, then twice weekly to maintain results. The mouthpiece holds your tongue and delivers neuromuscular electrical stimulation (NMES), a technique long used in physiotherapy to rebuild weak muscles. There is no mask, no air pressure, no tubing, and no noise.
- eXciteOSA is a daytime tongue trainer, not a nighttime device.
- It targets snoring and mild OSA, not severe or moderate-to-severe apnea.
- Used 20 minutes a day for six weeks, then twice weekly.
- It strengthens the tongue muscle rather than physically holding the airway open.
Does eXciteOSA Daytime Tongue Neurostimulation Reduce Snoring?
eXciteOSA does reduce snoring for most users, but the effect is modest and gradual. The strongest evidence comes from a multicenter trial by Baptista, Kotecha and colleagues, published in the Journal of Clinical Medicine in 2021 (NCT03829956, 115 completers). It measured both objective snoring sounds and bed-partner reports.
In that trial, 90% of participants showed some reduction in objective snoring, with a mean 41% drop in time spent snoring above 40 decibels (p<0.001). Bed-partner-reported snoring fell about 39% on a visual analogue scale, from 6.1 to 3.7. These are meaningful real-world changes for couples losing sleep over noise.
For mild OSA, the picture is more limited. In the mild-OSA subgroup, the mean apnea-hypopnea index (AHI), the count of breathing pauses per hour, dropped from 6.85 to 5.03 events per hour. The oxygen desaturation index fell from 5.68 to 4.33 (both p<0.001). Adherence to the daily 20-minute routine reached roughly 83%, with no serious adverse events.
- About 90% of trial users snored less; loud-snoring time fell roughly 41%.
- Mild-OSA AHI improved modestly, from 6.85 to 5.03 events per hour.
- Results require six weeks of daily, awake use.
- It is unproven for moderate-to-severe OSA.
How eXciteOSA Daytime Tongue Neurostimulation Compares: Mechanism Matters
The smartest way to choose a snoring therapy is by where your airway actually collapses. eXciteOSA targets tongue-base collapse by strengthening muscle. Other options work at different anatomical levels, which is why one device may help you while another does nothing.
| Option | How it works | Best for | Time to effect | Nighttime wear |
|---|---|---|---|---|
| eXciteOSA | Daytime tongue muscle training (NMES) | Snoring, mild OSA, tongue-base collapse | ~6 weeks | No |
| CPAP | Pressurised air splints the airway | Moderate-to-severe OSA | Same night | Yes, mask |
| Mandibular advancement device | Pulls jaw and tongue forward | Snoring, mild-moderate OSA | Days to weeks | Yes, mouth |
| Nasal strips | Open the outer nostrils | Mild nasal-origin snoring | Same night | Yes, external |
| Back2Sleep nasal stent | Soft silicone stent holds nasal and upper airway open | Nasal/velopharyngeal snoring, mild-to-moderate OSA | Same night | Yes, intranasal |
eXciteOSA and the Back2Sleep nasal stent share the same indication band, snoring and mild-to-moderate OSA, but they act at different levels. eXciteOSA rebuilds tongue strength over weeks. The Back2Sleep stent is a soft silicone tube that mechanically keeps the nasal passage and upper pharyngeal airway open the very first night. There is no electricity, no noise, and no tubing.
If your snoring comes from a blocked or narrow nose rather than your tongue, daytime tongue training may disappoint you. Tongue-strengthening exercises and stimulators address the back of the airway, as our guide to myofunctional therapy and tongue exercises explains in detail.
- Choose therapy by where your airway collapses, not by marketing.
- eXciteOSA fixes tongue-base collapse; nasal stents fix nasal-origin blockage.
- CPAP remains the standard for moderate-to-severe OSA.
- A nasal stent delivers same-night relief; eXciteOSA needs six weeks.
eXciteOSA in Europe: CE Mark, Prescription, and Cost
eXciteOSA carries a CE mark and has been recognised within UK supply pathways, but it is not a casual over-the-counter purchase. In most of Europe and the UK it is positioned as a clinician-supervised or prescription-style device, so you usually start through a sleep clinic or dentist rather than buying it freely online.
That matters for access. Public payers such as the NHS, France's Securite Sociale and Mutuelle, Germany's GKV/PKV, or Spain's Seguridad Social do not routinely reimburse eXciteOSA, so most EU buyers pay out of pocket, often several hundred euros. There can also be a wait for an appointment before you begin the six-week routine.
By contrast, the Back2Sleep nasal stent is a CE-certified Class I device sold direct to consumers across Europe, with no prescription, a starter kit of four sizes around EUR 39, and a 30-day money-back guarantee. It is not reimbursed by any payer, but its low out-of-pocket cost and same-night use make it a practical first step for nasal-origin snoring.
- eXciteOSA is CE-marked but usually clinician-supervised in the EU and UK.
- Public payers do not routinely reimburse it; expect out-of-pocket costs.
- Back2Sleep is no-prescription, CE Class I, around EUR 39, with 30-day money-back.
- Severe or undiagnosed OSA needs a medical sleep assessment.
Side Effects, Limits, and Who Should Skip It
eXciteOSA's side effects are minor and short-lived. In the 2021 trial, about 15% of users reported any adverse event. The most common were saliva pooling (10.4%), tongue discomfort (8.7%), tooth discomfort and tingling (6.1% each), and a metallic taste (2.6%). No serious adverse events occurred.
The bigger limits are clinical. eXciteOSA is not validated for moderate-to-severe OSA or central apnea, where stopping breathing repeatedly can strain the heart. If your snoring hides untreated OSA, a daytime muscle trainer is not a safe substitute for diagnosis and proven therapy.
This problem is widespread in Europe. Across European population studies, sleep-disordered breathing affects up to 20% of the community, and 4 to 5% of middle-aged adults meet criteria for OSA (European Respiratory Society / European Respiratory Journal, 2009). Chronic habitual snoring affects roughly 40% of men and 20% of women, and snoring occurs in 70 to 95% of people who have OSA (PMC/NCBI meta-regression, 2022).
Undertreatment is the real story. In a French population cohort, only 3.5% of adults were receiving sleep-apnea treatment, while 18.1% of untreated participants screened positive on the Berlin Questionnaire (European Respiratory Journal Open Research, 2023). That gap means many snorers reaching for eXciteOSA may actually need a formal diagnosis first.
- Side effects are minor: saliva, tongue or tooth discomfort, mild tingling.
- Not for moderate-to-severe or central apnea.
- Up to 20% of Europeans have sleep-disordered breathing; most go untreated.
- Persistent loud snoring deserves a sleep evaluation, not guesswork.
The Honest Verdict for EU Snorers
eXciteOSA daytime tongue neurostimulation is a legitimate, evidence-backed tool for reducing snoring loudness and helping mild OSA, but it is a slow burner. You commit to 20 minutes daily for six weeks, accept a modest AHI change, and usually go through a clinic to get it. For the right tongue-collapse profile, that effort pays off.
For many EU snorers, though, the smarter first step depends on mechanism and urgency. If your obstruction is nasal-driven, or you want relief tonight rather than in six weeks, a soft silicone nasal stent like Back2Sleep addresses the airway directly and affordably. It can also complement eXciteOSA for non-responders or people who cannot keep up daily awake therapy.
1Try eXciteOSA if
Your snoring is tongue-base driven, you have mild OSA, and you can commit to daily daytime sessions for six weeks with clinical guidance.
2Try a nasal stent if
Your snoring feels nose-driven, you want same-night relief, or you prefer a low-cost, no-prescription option to test before bigger commitments.
3Get a sleep study if
You snore loudly with daytime sleepiness, witnessed pauses, or morning headaches. These signal possible moderate-to-severe OSA needing CPAP-level care.
- eXciteOSA works but demands six weeks and daily discipline.
- Nasal-origin snorers may do better with a nasal stent first.
- A stent offers same-night, low-cost relief and can complement eXciteOSA.
- Always rule out serious OSA before self-treating.
What Back2Sleep Users Say
Frequently Asked Questions
Does eXciteOSA actually work to reduce snoring?
Yes, for most users. In a 2021 multicenter trial (Baptista, Kotecha et al.), 90% of participants snored less, with loud-snoring time falling about 41% and bed-partner-rated snoring dropping roughly 39%. The effect is real but modest, and it builds gradually over six weeks of daily 20-minute sessions rather than overnight.
How long does it take to see results with eXciteOSA?
Most people need about six weeks of daily 20-minute sessions before snoring noticeably improves, because the device strengthens tongue muscle over time. After the six-week phase, you switch to twice-weekly maintenance sessions. If you want same-night relief instead of waiting weeks, a mechanical option like a nasal stent acts immediately.
How much does eXciteOSA cost and is it covered by insurance or the NHS?
In Europe and the UK, eXciteOSA is typically an out-of-pocket purchase costing several hundred euros, often through a clinic. Public payers such as the NHS, Securite Sociale or GKV do not routinely reimburse it. By comparison, a Back2Sleep nasal-stent starter kit costs around EUR 39 with a 30-day money-back guarantee.
What are the side effects of eXciteOSA tongue stimulation?
Side effects are minor and transient. In the 2021 trial, about 15% of users reported any adverse event, most often saliva pooling (10.4%), tongue discomfort (8.7%), tooth discomfort and tingling (6.1% each), and a metallic taste (2.6%). No serious adverse events occurred, and most sensations fade with continued use.
Is eXciteOSA better than CPAP for mild sleep apnea?
For mild OSA, eXciteOSA is gentler and mask-free, but its effect is small, lowering trial AHI from 6.85 to 5.03 events per hour. CPAP works the same night and remains the proven standard for moderate-to-severe OSA. eXciteOSA suits people who refuse CPAP and have only mild, tongue-related obstruction, not severe apnea.
Can you use eXciteOSA for severe obstructive sleep apnea?
No. eXciteOSA is validated only for primary snoring and mild OSA, not moderate-to-severe or central apnea. Severe OSA repeatedly drops oxygen levels and strains the heart, so it needs proven therapy like CPAP. If you have loud snoring with daytime sleepiness, get a sleep evaluation before self-treating.
Do you need a prescription to buy eXciteOSA in the UK or Europe?
Generally yes. In the UK and most of Europe, eXciteOSA is supplied as a clinician-supervised or prescription-style device, usually started through a sleep clinic or dentist. This differs from a CE-certified Class I nasal stent like Back2Sleep, which is sold direct to consumers across Europe with no prescription required.
Is eXciteOSA available in Europe and does it have a CE mark?
Yes, eXciteOSA is CE-marked and available in parts of Europe and the UK, often through clinics rather than open retail. The CE mark confirms regulatory conformity but does not mean automatic reimbursement. Most EU buyers pay out of pocket, so weigh the cost and six-week commitment against faster, lower-cost alternatives.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.